輸液ポンプソフトウェア市場の2028年までの予測- タイプ別（臨床ワークフローソフトウェア、投与エラー削減ソフトウェア、相互運用性ソフトウェア）、適応症別、用途別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、輸液ポンプソフトウェアの世界市場は、2022年に9億6,350万米ドルを占め、2028年には16億2,490万米ドルに達すると予測され、予測期間中に9.1%のCAGRで成長するとされています。

輸液ポンプと呼ばれるポンプ群は、薬や栄養などの物質を輸送するために使用されます。ソフトウェアは、液体を移送する速度を制御します。また、ソフトウェアは、安全性などの重要なタスクの中でも、ペースを維持するためのポンプ機構とユーザーインターフェイスを制御します。このポンプは外付けの機器です。ポンプは、動脈、静脈、皮下の経路でこれらの液体を移動させます。外科手術の件数が増加傾向にあることから、このような国々では輸液ポンプの機会が増えており、それが最終的に輸液ポンプに使用されるソフトウェアの需要を牽引しています。

Journal of Infectious Disease Adviserによると、米国では毎年約2,700万件の外科手術が行われています。

市場力学：

促進要因

研究開発活動の成長

慢性疾患の増加や病院での輸液療法にかかる費用の上昇を受け、在宅輸液ソリューションの研究開発活動が盛んに行われています。例えば、糖尿病、がん、神経疾患などの患者さんの中には、できれば自宅で長期的なケアを必要とする人が増えています。さらに、高齢化社会における長期療養の必要性が、在宅輸液療法を目的とした新製品の開発を後押ししています。

抑制要因

規制の厳しさ

ポンプの製造や使用に関する規制が厳しくなっており、新しい機器の承認プロセスが遅くなっています。このため、市場の拡大が遅れることが予想されます。さらに、製造上のミスによる製品回収の増加も、市場拡大の妨げとなっています。例えば、輸液アラーム、優先度の低いキープベインオープン（KVO）、複数のソフトウェアエラーが原因で、2019年8月にVigilant AgiliaドラッグライブラリとVolume MC Agilia輸液ポンプをリコールしました。

機会

外来用ポンプへの需要の高まり

さまざまな医療現場での薬物投与に重要なツールが外来用ポンプです。病院や家庭で患者に鎮痛剤、化学療法、輸液、その他の治療を行う際に欠かせないものです。先進国では、病院での管理に伴う経済的制約を軽減するために、慢性疾患のケアを現場で行う動きがあるため、携帯型ポンプの市場は近い将来、上昇すると予測されます。

脅威

薬剤ミスの頻度が高まっているにもかかわらず、ほとんどの病院では無線アクセスがないです。

単位、10の倍数、計算ミス、プッシュボタンエラーは、最も典型的な輸液トラブルの一つです。輸液ポンプのプログラミングにおいて、小数の入力ミスは致命的な結果を招く可能性があります。これらの問題に対処し、現在のスマートポンプを新しいレベルの「インテリジェント」輸液システムに進化させるには、輸液ポンプとバーコード投薬管理（BCMA）システム、病院情報システム（HIS）、電子医療記録（EMR）の無線接続が必要となります。輸液ポンプ市場は、無線接続の不備や病院の支出制限の結果、ほとんどの病院でスマート輸液デバイスと病院情報システムの互換性がないことから、大きな障害に直面しています。

COVID-19の影響：

COVID-19のパンデミックの影響とその寿命の不確実性により、業界の成長率は大幅に上昇しました。2020年のCOVID-19検査の増加がその原因のほとんどを占めています。しかし、COVID-19の流行による労働力不足やサプライチェーンの寸断による生産量の減少があっています。重要な関係者は、目まぐるしく変化する状況に対応して戦術を変更し続けています。ヘルスケア部門は、COVID-19による深刻な長期的影響を受けると予想されます。この問題が解決されるまで、国や利害関係者が優先的にヘルスケア改革を実施する必要があります。

予測期間中、インスリン注入部門が最大となる見込み

インスリン注入分野は、顕著に高い成長率で増加し、その優位性を維持するため、有利な成長を遂げると推定されます。これは、世界の1型糖尿病患者数の増加や、インスリンポンプ分野における有望な技術開発によるものです。今後数年間は、疼痛治療におけるPCAポンプの用途が拡大し、世界的に製品需要が増加すると予測されます。

予測期間中に最もCAGRが高くなると予想される病院分野

病院分野は、最も高価な輸液装置、これらの施設を利用する膨大な患者数、ポンプを操作する熟練したスタッフの確保などの理由から、予測期間中に最も速いCAGRの成長が見込まれており、病院分野が市場で最大のシェアを占めています。しかし、外来用ポンプの使用の増加や、コスト負担を軽減するためのケア現場管理への需要の高まりから、在宅ケア環境部門がシェアを伸ばしています。

最もシェアが高い地域

北米は、在宅ヘルスケア産業、患者、医師が慢性疾患の日常的な管理のために常に新しい最先端のソリューションを受け入れているため、北米の輸液ポンプソフトウェア市場の現在の拡大には大きな責任があると考えられ、予測期間中に最も高い市場シェアを維持すると予測されます。輸液ポンプソフトウェアは、患者の意識の高まり、慢性疾患の有病率の上昇、手術件数の増加、ヘルスケアコストの上昇を抑制する必要性から、この地域で大きな成長を遂げました。

CAGRが最も高い地域：

アジア太平洋地域は、糖尿病やがんなどの慢性疾患の増加、医療インフラの拡大、GDPの増加、可処分所得の増加、高度な治療法へのアクセスに対する意識の高まりなどの要因から、予測期間中に最も高いCAGRを示すと予測されます。しかし、これらの地域では、大手企業がより一層の拠点拡大に注力しているため、市場は拡大すると思われます。

主な発展：

2023年5月、バクスターがバイオファーマ・ソリューションズ事業をアドベント・インターナショナルとウォーバーグ・ピンカスに42億5,000万米ドルで売却する正式契約に調印。

2023年4月、バクスターが米国でゾシンプレミックスを発売。ゾシンプレミックスは、感受性細菌による複数の感染症の治療に適応し、バクスター独自の1回分ギャラクシー容器で提供されます。

本レポートが提供するもの

• 地域別および国別セグメントの市場シェア評価
• 新規参入企業への戦略的提言
• 2020年、2021年、2022年、2025年、2028年の市場データを網羅
• 市場動向（促進要因、抑制要因、機会、脅威、課題、投資機会、推奨事項）
• 市場推定に基づく、主要ビジネスセグメントにおける戦略的提言
• 主要な共通トレンドをマッピングした競合情勢。
• 詳細な戦略、財務、最近の開発状況を含む企業プロファイル
• 最新の技術的進歩をマッピングしたサプライチェーン動向

無料のカスタマイズ提供：

本レポートをご購入いただいたお客様には、以下の無料カスタマイズオプションのいずれかを提供させていただきます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的なプロファイリング（最大3社まで）
  • 主要プレイヤーのSWOT分析（3社まで）
• 地域別セグメンテーション
  • お客様のご希望に応じて、主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる。）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地域的プレゼンス、戦略的提携に基づく主要プレイヤーのベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 仮定

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の輸液ポンプソフトウェア市場：タイプ別

• 臨床ワークフローソフトウェア
• 線量誤差低減ソフトウェア（DERS）
• 相互運用性ソフトウェア

第6章 世界の輸液ポンプソフトウェア市場：適応症別

• インスリン点滴
• 化学療法
• 痛みと麻酔の管理
• 一般的な輸液
• 経腸注入

第7章 世界の輸液ポンプソフトウェア市場：用途別

• 腫瘍学
• 糖尿病
• 疼痛管理
• その他の用途

第8章 世界の輸液ポンプソフトウェア市場：エンドユーザー別

• 外来センターの設定
• 在宅ヘルスケアの設定
• 病院
• 学術調査機関

第9章 世界の輸液ポンプソフトウェア市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 会社概要

• Baxter International
• Becton, Dickinson and Company
• B. Braun Medical Inc.
• FLOWONIX MEDICAL INC
• Medtronic
• Merck KGaA
• Smiths Medical
• Q Core Medical Ltd
• Fresenius Kabi
• ICU Medical Inc.
• Roche Diagnostics
• Agilent Technologies
• Terumo Medical
• Micrel Medical Devices
• Ypsomed
• F. Hoffmann-La Roche

List of Tables

• Table 1 Global Infusion Pump Software Market Outlook, By Region (2020-2028) ($MN)
• Table 2 Global Infusion Pump Software Market Outlook, By Type (2020-2028) ($MN)
• Table 3 Global Infusion Pump Software Market Outlook, By Clinical Workflow Software (2020-2028) ($MN)
• Table 4 Global Infusion Pump Software Market Outlook, By Dose Error Reduction Software (DERS) (2020-2028) ($MN)
• Table 5 Global Infusion Pump Software Market Outlook, By Interoperability Software (2020-2028) ($MN)
• Table 6 Global Infusion Pump Software Market Outlook, By Indication (2020-2028) ($MN)
• Table 7 Global Infusion Pump Software Market Outlook, By Insulin Infusion (2020-2028) ($MN)
• Table 8 Global Infusion Pump Software Market Outlook, By Chemotherapy (2020-2028) ($MN)
• Table 9 Global Infusion Pump Software Market Outlook, By Pain & Anesthesia Management (2020-2028) ($MN)
• Table 10 Global Infusion Pump Software Market Outlook, By General Infusion (2020-2028) ($MN)
• Table 11 Global Infusion Pump Software Market Outlook, By Enteral Infusion (2020-2028) ($MN)
• Table 12 Global Infusion Pump Software Market Outlook, By Application (2020-2028) ($MN)
• Table 13 Global Infusion Pump Software Market Outlook, By Oncology (2020-2028) ($MN)
• Table 14 Global Infusion Pump Software Market Outlook, By Diabetes (2020-2028) ($MN)
• Table 15 Global Infusion Pump Software Market Outlook, By Pain Management (2020-2028) ($MN)
• Table 16 Global Infusion Pump Software Market Outlook, By Other Applications (2020-2028) ($MN)
• Table 17 Global Infusion Pump Software Market Outlook, By End User (2020-2028) ($MN)
• Table 18 Global Infusion Pump Software Market Outlook, By Ambulatory Centers Settings (2020-2028) ($MN)
• Table 19 Global Infusion Pump Software Market Outlook, By Home Healthcare Settings (2020-2028) ($MN)
• Table 20 Global Infusion Pump Software Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 21 Global Infusion Pump Software Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
• Table 22 North America Infusion Pump Software Market Outlook, By Country (2020-2028) ($MN)
• Table 23 North America Infusion Pump Software Market Outlook, By Type (2020-2028) ($MN)
• Table 24 North America Infusion Pump Software Market Outlook, By Clinical Workflow Software (2020-2028) ($MN)
• Table 25 North America Infusion Pump Software Market Outlook, By Dose Error Reduction Software (DERS) (2020-2028) ($MN)
• Table 26 North America Infusion Pump Software Market Outlook, By Interoperability Software (2020-2028) ($MN)
• Table 27 North America Infusion Pump Software Market Outlook, By Indication (2020-2028) ($MN)
• Table 28 North America Infusion Pump Software Market Outlook, By Insulin Infusion (2020-2028) ($MN)
• Table 29 North America Infusion Pump Software Market Outlook, By Chemotherapy (2020-2028) ($MN)
• Table 30 North America Infusion Pump Software Market Outlook, By Pain & Anesthesia Management (2020-2028) ($MN)
• Table 31 North America Infusion Pump Software Market Outlook, By General Infusion (2020-2028) ($MN)
• Table 32 North America Infusion Pump Software Market Outlook, By Enteral Infusion (2020-2028) ($MN)
• Table 33 North America Infusion Pump Software Market Outlook, By Application (2020-2028) ($MN)
• Table 34 North America Infusion Pump Software Market Outlook, By Oncology (2020-2028) ($MN)
• Table 35 North America Infusion Pump Software Market Outlook, By Diabetes (2020-2028) ($MN)
• Table 36 North America Infusion Pump Software Market Outlook, By Pain Management (2020-2028) ($MN)
• Table 37 North America Infusion Pump Software Market Outlook, By Other Applications (2020-2028) ($MN)
• Table 38 North America Infusion Pump Software Market Outlook, By End User (2020-2028) ($MN)
• Table 39 North America Infusion Pump Software Market Outlook, By Ambulatory Centers Settings (2020-2028) ($MN)
• Table 40 North America Infusion Pump Software Market Outlook, By Home Healthcare Settings (2020-2028) ($MN)
• Table 41 North America Infusion Pump Software Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 42 North America Infusion Pump Software Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
• Table 43 Europe Infusion Pump Software Market Outlook, By Country (2020-2028) ($MN)
• Table 44 Europe Infusion Pump Software Market Outlook, By Type (2020-2028) ($MN)
• Table 45 Europe Infusion Pump Software Market Outlook, By Clinical Workflow Software (2020-2028) ($MN)
• Table 46 Europe Infusion Pump Software Market Outlook, By Dose Error Reduction Software (DERS) (2020-2028) ($MN)
• Table 47 Europe Infusion Pump Software Market Outlook, By Interoperability Software (2020-2028) ($MN)
• Table 48 Europe Infusion Pump Software Market Outlook, By Indication (2020-2028) ($MN)
• Table 49 Europe Infusion Pump Software Market Outlook, By Insulin Infusion (2020-2028) ($MN)
• Table 50 Europe Infusion Pump Software Market Outlook, By Chemotherapy (2020-2028) ($MN)
• Table 51 Europe Infusion Pump Software Market Outlook, By Pain & Anesthesia Management (2020-2028) ($MN)
• Table 52 Europe Infusion Pump Software Market Outlook, By General Infusion (2020-2028) ($MN)
• Table 53 Europe Infusion Pump Software Market Outlook, By Enteral Infusion (2020-2028) ($MN)
• Table 54 Europe Infusion Pump Software Market Outlook, By Application (2020-2028) ($MN)
• Table 55 Europe Infusion Pump Software Market Outlook, By Oncology (2020-2028) ($MN)
• Table 56 Europe Infusion Pump Software Market Outlook, By Diabetes (2020-2028) ($MN)
• Table 57 Europe Infusion Pump Software Market Outlook, By Pain Management (2020-2028) ($MN)
• Table 58 Europe Infusion Pump Software Market Outlook, By Other Applications (2020-2028) ($MN)
• Table 59 Europe Infusion Pump Software Market Outlook, By End User (2020-2028) ($MN)
• Table 60 Europe Infusion Pump Software Market Outlook, By Ambulatory Centers Settings (2020-2028) ($MN)
• Table 61 Europe Infusion Pump Software Market Outlook, By Home Healthcare Settings (2020-2028) ($MN)
• Table 62 Europe Infusion Pump Software Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 63 Europe Infusion Pump Software Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
• Table 64 Asia Pacific Infusion Pump Software Market Outlook, By Country (2020-2028) ($MN)
• Table 65 Asia Pacific Infusion Pump Software Market Outlook, By Type (2020-2028) ($MN)
• Table 66 Asia Pacific Infusion Pump Software Market Outlook, By Clinical Workflow Software (2020-2028) ($MN)
• Table 67 Asia Pacific Infusion Pump Software Market Outlook, By Dose Error Reduction Software (DERS) (2020-2028) ($MN)
• Table 68 Asia Pacific Infusion Pump Software Market Outlook, By Interoperability Software (2020-2028) ($MN)
• Table 69 Asia Pacific Infusion Pump Software Market Outlook, By Indication (2020-2028) ($MN)
• Table 70 Asia Pacific Infusion Pump Software Market Outlook, By Insulin Infusion (2020-2028) ($MN)
• Table 71 Asia Pacific Infusion Pump Software Market Outlook, By Chemotherapy (2020-2028) ($MN)
• Table 72 Asia Pacific Infusion Pump Software Market Outlook, By Pain & Anesthesia Management (2020-2028) ($MN)
• Table 73 Asia Pacific Infusion Pump Software Market Outlook, By General Infusion (2020-2028) ($MN)
• Table 74 Asia Pacific Infusion Pump Software Market Outlook, By Enteral Infusion (2020-2028) ($MN)
• Table 75 Asia Pacific Infusion Pump Software Market Outlook, By Application (2020-2028) ($MN)
• Table 76 Asia Pacific Infusion Pump Software Market Outlook, By Oncology (2020-2028) ($MN)
• Table 77 Asia Pacific Infusion Pump Software Market Outlook, By Diabetes (2020-2028) ($MN)
• Table 78 Asia Pacific Infusion Pump Software Market Outlook, By Pain Management (2020-2028) ($MN)
• Table 79 Asia Pacific Infusion Pump Software Market Outlook, By Other Applications (2020-2028) ($MN)
• Table 80 Asia Pacific Infusion Pump Software Market Outlook, By End User (2020-2028) ($MN)
• Table 81 Asia Pacific Infusion Pump Software Market Outlook, By Ambulatory Centers Settings (2020-2028) ($MN)
• Table 82 Asia Pacific Infusion Pump Software Market Outlook, By Home Healthcare Settings (2020-2028) ($MN)
• Table 83 Asia Pacific Infusion Pump Software Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 84 Asia Pacific Infusion Pump Software Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
• Table 85 South America Infusion Pump Software Market Outlook, By Country (2020-2028) ($MN)
• Table 86 South America Infusion Pump Software Market Outlook, By Type (2020-2028) ($MN)
• Table 87 South America Infusion Pump Software Market Outlook, By Clinical Workflow Software (2020-2028) ($MN)
• Table 88 South America Infusion Pump Software Market Outlook, By Dose Error Reduction Software (DERS) (2020-2028) ($MN)
• Table 89 South America Infusion Pump Software Market Outlook, By Interoperability Software (2020-2028) ($MN)
• Table 90 South America Infusion Pump Software Market Outlook, By Indication (2020-2028) ($MN)
• Table 91 South America Infusion Pump Software Market Outlook, By Insulin Infusion (2020-2028) ($MN)
• Table 92 South America Infusion Pump Software Market Outlook, By Chemotherapy (2020-2028) ($MN)
• Table 93 South America Infusion Pump Software Market Outlook, By Pain & Anesthesia Management (2020-2028) ($MN)
• Table 94 South America Infusion Pump Software Market Outlook, By General Infusion (2020-2028) ($MN)
• Table 95 South America Infusion Pump Software Market Outlook, By Enteral Infusion (2020-2028) ($MN)
• Table 96 South America Infusion Pump Software Market Outlook, By Application (2020-2028) ($MN)
• Table 97 South America Infusion Pump Software Market Outlook, By Oncology (2020-2028) ($MN)
• Table 98 South America Infusion Pump Software Market Outlook, By Diabetes (2020-2028) ($MN)
• Table 99 South America Infusion Pump Software Market Outlook, By Pain Management (2020-2028) ($MN)
• Table 100 South America Infusion Pump Software Market Outlook, By Other Applications (2020-2028) ($MN)
• Table 101 South America Infusion Pump Software Market Outlook, By End User (2020-2028) ($MN)
• Table 102 South America Infusion Pump Software Market Outlook, By Ambulatory Centers Settings (2020-2028) ($MN)
• Table 103 South America Infusion Pump Software Market Outlook, By Home Healthcare Settings (2020-2028) ($MN)
• Table 104 South America Infusion Pump Software Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 105 South America Infusion Pump Software Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
• Table 106 Middle East & Africa Infusion Pump Software Market Outlook, By Country (2020-2028) ($MN)
• Table 107 Middle East & Africa Infusion Pump Software Market Outlook, By Type (2020-2028) ($MN)
• Table 108 Middle East & Africa Infusion Pump Software Market Outlook, By Clinical Workflow Software (2020-2028) ($MN)
• Table 109 Middle East & Africa Infusion Pump Software Market Outlook, By Dose Error Reduction Software (DERS) (2020-2028) ($MN)
• Table 110 Middle East & Africa Infusion Pump Software Market Outlook, By Interoperability Software (2020-2028) ($MN)
• Table 111 Middle East & Africa Infusion Pump Software Market Outlook, By Indication (2020-2028) ($MN)
• Table 112 Middle East & Africa Infusion Pump Software Market Outlook, By Insulin Infusion (2020-2028) ($MN)
• Table 113 Middle East & Africa Infusion Pump Software Market Outlook, By Chemotherapy (2020-2028) ($MN)
• Table 114 Middle East & Africa Infusion Pump Software Market Outlook, By Pain & Anesthesia Management (2020-2028) ($MN)
• Table 115 Middle East & Africa Infusion Pump Software Market Outlook, By General Infusion (2020-2028) ($MN)
• Table 116 Middle East & Africa Infusion Pump Software Market Outlook, By Enteral Infusion (2020-2028) ($MN)
• Table 117 Middle East & Africa Infusion Pump Software Market Outlook, By Application (2020-2028) ($MN)
• Table 118 Middle East & Africa Infusion Pump Software Market Outlook, By Oncology (2020-2028) ($MN)
• Table 119 Middle East & Africa Infusion Pump Software Market Outlook, By Diabetes (2020-2028) ($MN)
• Table 120 Middle East & Africa Infusion Pump Software Market Outlook, By Pain Management (2020-2028) ($MN)
• Table 121 Middle East & Africa Infusion Pump Software Market Outlook, By Other Applications (2020-2028) ($MN)
• Table 122 Middle East & Africa Infusion Pump Software Market Outlook, By End User (2020-2028) ($MN)
• Table 123 Middle East & Africa Infusion Pump Software Market Outlook, By Ambulatory Centers Settings (2020-2028) ($MN)
• Table 124 Middle East & Africa Infusion Pump Software Market Outlook, By Home Healthcare Settings (2020-2028) ($MN)
• Table 125 Middle East & Africa Infusion Pump Software Market Outlook, By Hospitals (2020-2028) ($MN)
• Table 126 Middle East & Africa Infusion Pump Software Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)

According to Stratistics MRC, the Global Infusion Pump Software Market is accounted for $963.5 million in 2022 and is expected to reach $1,624.9 million by 2028 growing at a CAGR of 9.1% during the forecast period. A group of pumps called infusion pumps are used to transport substances like medications and nutrition. Software controls the rates at which the fluids are transferred. The software also controls the pumping mechanism to maintain the pace and the user interface, among other crucial tasks like safety. These pumps are outside equipment. The pump moves these fluids through arterial, intravenous, and subcutaneous pathways. This rising trend of the number of surgical procedures performed is indicating that there is a growing opportunity for the infusion pumps in such countries which is ultimately driving the demand for the software used for infusion pump.

According to the Journal of Infectious Disease Adviser, approximately 27 million surgical procedures are performed in the United States each year.

Market Dynamics:

Driver:

Growing research and development activities

Growing research and development efforts are being made to create home-based infusion solutions as a result of the rising prevalence of chronic illnesses and the rising expense of hospital-based infusion therapies. For instance, an increasing number of people with diabetes, cancer, and neurological illnesses are in need of long-term care, preferably at home. Furthermore, the necessity for long-term care therapies among an ageing population is fuelling the development of new products aimed at home-based infusion therapies.

Restraint:

Stringent Regulations

Regulations governing the manufacture and use of pumps are becoming more onerous, which slows down the approval process for new devices. This aspect is projected to slow market expansion. Additionally, a growing number of product recalls brought on by manufacturing mistakes are limiting market expansion. For example, recalled the Vigilant Agilia drug library and the Volume MC Agilia infusion pump in August 2019 due to infusion alarm, low priority keep vein open (KVO), and multiple software errors.

Opportunity:

Growing demand for ambulatory pumps

An important tool for medication administration in a variety of medical settings is the ambulatory pump. They are essential in giving patients analgesics, chemotherapy, TPN infusions, and other treatments in hospitals and at home. The market for portable pumps is projected to rise in the near future due to the move towards site of care management of chronic illnesses in industrialised nations in order to reduce the financial constraints associated with hospital-based management.

Threat:

The frequency of pharmaceutical mistakes is rising, yet most hospitals lack wireless access

Unit, multiples of ten, computation, and push-button errors are some of the most typical infusion problems. When programming infusion pumps, decimal entry mistakes can have fatal consequence to address these issues and advance the present smart pumps to a new level of "intelligent" infusion systems, wireless connection of infusion pumps with the Barcoded Medication Administration (BCMA) system, the Hospital Information System (HIS), and the Electronic Medical Record (EMR) is necessary. The market for infusion pumps faces a substantial obstacle from the lack of compatibility between smart infusion devices and hospital information systems in most hospitals as a result of poor wireless connectivity and limited hospital spending.

COVID-19 Impact:

The COVID-19 pandemic's effects and the uncertainty surrounding its longevity have caused a significant increase in the industry's growth rate. The rise in COVID-19 testing in 2020 is mostly to blame for this. However, there was a reduction in output as a result of the COVID-19 epidemic due to labour shortages and supply chain interruptions. Important parties are continuing to modify their tactics in response to the fast shifting circumstances. The healthcare sector is expected to see severe long-term effects from COVID-19. Prioritised healthcare reforms would need to be implemented by nations and significant stakeholders until the issue is resolved.

The insulin infusion segment is expected to be the largest during the forecast period

The insulin infusion segment is estimated to have a lucrative growth, due to increase at a noticeably high growth rate, maintaining its dominance. This is due to an increase in the number of type 1 diabetes patients worldwide and the development of promising technology in the area of insulin pumps. In the upcoming years, expanding PCA pump uses in pain treatment are projected to increase product demand globally.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the most expensive infusion devices, huge patient population using these facilities, and availability of skilled staff to operate the pump, the hospitals sector held the greatest share of the market. However, due to the rising use of ambulatory pumps and growing demand for site of care management to lower cost burden, the home care settings segment.

Region with highest share:

North America is projected to hold the highest market share during the forecast period owing to the home healthcare industry, patients, and doctors are largely to blame for the present expansion of the North American infusion pump software market as they consistently embrace new, cutting-edge solutions for the routine management of chronic medical conditions. Infusion pump software has seen significant growth in the region due to increased patient awareness, the rising prevalence of chronic diseases, and an increase in the number of surgeries performed there, and the need to rein in rising healthcare costs.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to some of the factors include the rise in the prevalence of chronic diseases like diabetes and cancer, expanding healthcare infrastructure, growing GDP, an increase in disposable income, and rising awareness of the accessibility of advanced therapies in the Asia Pacific region. However, the market in these regions will grow as major firms focus more on expanding their footprint.

Key players in the market:

Some of the key players profiled in the Infusion Pump Software Market include Baxter International, Becton, Dickinson and Company, B. Braun Medical Inc., FLOWONIX MEDICAL INC, Medtronic, Merck KGaA, Smiths Medical, Q Core Medical Ltd, Fresenius Kabi, ICU Medical Inc., Roche Diagnostics, Agilent Technologies, Terumo Medical, Micrel Medical Devices, Ypsomed and F. Hoffmann-La Roche

Key Developments:

In May 2023, Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion.

In April 2023, Baxter Launches Zosyn Premix in US, Zosyn premix is indicated for the treatment of multiple infections caused by susceptible bacteria and is available in Baxter's proprietary single-dose Galaxy containers.

Types Covered:

• Clinical Workflow Software
• Dose Error Reduction Software (DERS)
• Interoperability Software

Indications Covered:

• Insulin Infusion
• Chemotherapy
• Pain & Anesthesia Management
• General Infusion
• Enteral Infusion

Applications Covered:

• Oncology
• Diabetes
• Pain Management
• Other Applications

End Users Covered:

• Ambulatory Centers Settings
• Home Healthcare Settings
• Hospitals
• Academic & Research Institutes

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Infusion Pump Software Market, By Type

• 5.1 Introduction
• 5.2 Clinical Workflow Software
• 5.3 Dose Error Reduction Software (DERS)
• 5.4 Interoperability Software

6 Global Infusion Pump Software Market, By Indication

• 6.1 Introduction
• 6.2 Insulin Infusion
• 6.3 Chemotherapy
• 6.4 Pain & Anesthesia Management
• 6.5 General Infusion
• 6.6 Enteral Infusion

7 Global Infusion Pump Software Market, By Application

• 7.1 Introduction
• 7.2 Oncology
• 7.3 Diabetes
• 7.4 Pain Management
• 7.5 Other Applications

8 Global Infusion Pump Software Market, By End User

• 8.1 Introduction
• 8.2 Ambulatory Centers Settings
• 8.3 Home Healthcare Settings
• 8.4 Hospitals
• 8.5 Academic & Research Institutes

9 Global Infusion Pump Software Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Baxter International
• 11.2 Becton, Dickinson and Company
• 11.3 B. Braun Medical Inc.
• 11.4 FLOWONIX MEDICAL INC
• 11.5 Medtronic
• 11.6 Merck KGaA
• 11.7 Smiths Medical
• 11.8 Q Core Medical Ltd
• 11.9 Fresenius Kabi
• 11.10 ICU Medical Inc.
• 11.11 Roche Diagnostics
• 11.12 Agilent Technologies
• 11.11 Terumo Medical
• 11.14 Micrel Medical Devices
• 11.15 Ypsomed
• 11.16 F. Hoffmann-La Roche